Article ; Online: The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver.
2021 Volume 459, Page(s) 152854
Abstract: A methylimidizolium ionic liquid (M8OI) was recently found to be contaminating the environment and to be related to and/or potentially a component of an environmental trigger for the autoimmune liver disease primary biliary cholangitis (PBC). The aims of ...
| Abstract | A methylimidizolium ionic liquid (M8OI) was recently found to be contaminating the environment and to be related to and/or potentially a component of an environmental trigger for the autoimmune liver disease primary biliary cholangitis (PBC). The aims of this study were to investigate human exposure to M8OI, hepatic metabolism and excretion. PBC patient and control sera were screened for the presence of M8OI. Human livers were perfused with 50μM M8OI in a closed circuit and its hepatic disposition examined. Metabolism was examined in cultured human hepatocytes and differentiated HepaRG cells by the addition of M8OI and metabolites in the range 10-100 μM. M8OI was detected in the sera from 5/20 PBC patients and 1/10 controls. In perfused livers, M8OI was cleared from the plasma with its appearance - primarily in the form of its hydroxylated (HO8IM) and carboxylated (COOH7IM) products - in the bile. Metabolism was reflected in cultured hepatocytes with HO8IM production inhibited by the cytochrome P450 inhibitor ketoconazole. Further oxidation of HO8IM to COOH7IM was sequentially inhibited by the alcohol and acetaldehyde dehydrogenase inhibitors 4-methyl pyrazole and disulfiram respectively. Hepatocytes from 1 donor failed to metabolise M8OI to COOH7IM over a 24 h period. These results demonstrate exposure to M8OI in the human population, monooxygenation by cytochromes P450 followed by alcohol and acetaldehyde dehydrogenase oxidation to a carboxylic acid that are excreted, in part, via the bile in human liver. |
|---|---|
| MeSH term(s) | Adult ; Aged ; Alcohol Dehydrogenase/antagonists & inhibitors ; Aldehyde Oxidoreductases/antagonists & inhibitors ; Cells, Cultured ; Cytochrome P-450 Enzyme Inhibitors/pharmacology ; Enzyme Inhibitors/pharmacology ; Female ; Hepatobiliary Elimination ; Hepatocytes/drug effects ; Hepatocytes/metabolism ; Humans ; Hydroxylation ; Imidazoles/blood ; Imidazoles/pharmacokinetics ; In Vitro Techniques ; Ketoconazole/pharmacology ; Male ; Middle Aged ; Primary Cell Culture ; Young Adult |
| Chemical Substances | Cytochrome P-450 Enzyme Inhibitors ; Enzyme Inhibitors ; Imidazoles ; M8OI compound ; Alcohol Dehydrogenase (EC 1.1.1.1) ; Aldehyde Oxidoreductases (EC 1.2.-) ; aldehyde dehydrogenase (NAD(P)+) (EC 1.2.1.5) ; Ketoconazole (R9400W927I) |
| Language | English |
| Publishing date | 2021-07-13 |
| Publishing country | Ireland |
| Document type | Journal Article ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 184557-3 |
| ISSN | 1879-3185 ; 0300-483X |
| ISSN (online) | 1879-3185 |
| ISSN | 0300-483X |
| DOI | 10.1016/j.tox.2021.152854 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 888: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.